Clinical Trial Update: Rocket Study: A Study to Characterize Biomarkers and Disease Progression in Participants With Pelizaeus-Merzbacher Disease

View source ↗

Summary

Ionis Pharmaceuticals is conducting a study to characterize biomarkers and disease progression in Pelizaeus-Merzbacher Disease. The trial status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pelizaeus-merzbacher Disease

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Pelizaeus-Merzbacher Disease | Status: RECRUITING